Dr. Vishnu Priya

Qualification               : Ph.D.

Specialization             : Pharmaceutics

E mail                          : vishnu.priya@nmims.edu

Phone                          : 022-42332000 (Extn- 2093)

Experience                  : 1 year (academic experience)

My doctoral research was mainly in the area of "Development and Characterization of Targeted nanomedicines for the Treatment of Thrombotic Diseases”. I have gained knowledge of the various skills necessary for drug delivery over the journey of my six years of research (Master’s and Ph. D.), including drug selection and polymers, polymer modification and chemical characterization, preparation methods of nanomedicine (liposomes, mesoporous silica structures, ethosomes, nanogel, micelles, and nanoparticles), conjugation techniques for active targeting approaches, interpretation of spectroscopic techniques, in-vitro, and in-vivo characterizations etc.

Interest areas:

• Antithrombotic nanomedicine

• Nanotechnology based drug delivery
• Novel drug delivery systems

Research

• Publications – 19 (International-19, National- 0)
• Book Chapters- 02
• Presentations- Total number (International- 02, National- 03)

Conferences/Workshops/Seminars attended- 08

Awards

• Awarded Teaching Assistantship during Ph.D. (2018-2023)
• Awarded AICTE fellowship during M. Pharm (2015-2017)

• Qualified three times Graduate Pharmacy Aptitude Test (GPAT), Secured AIR-170 Rank in GPAT 2015

• Awarded as Excellor in quiz contest "Pharma talent hunt 2011-2014” organized by Leaders Academy

Professional Memberships

            Registered Pharmacist (Bihar Pharmacy Council, Patna)

Recent Publications

1. Priya, V., Vikas, Mehata, A.K., Jain, D., Singh, S.K. and Muthu, M.S., (2022). Efficient delivery of abciximab using mesoporous silica nanoparticles: in-vitro assessment for targeted and improved antithrombotic activity. Colloids and Surfaces B: Biointerfaces 218, 112697. (Impact factor: 5.999)
2. Priya, V., Singh, S.K., Revand, R., Kumar, S., Mehata, A.K., Sushmitha, P., Mahto, S.K. and Muthu, M.S., (2022). GPIIb/IIIa Receptor targeted rutin loaded liposomes for site-specific antithrombotic effect. Molecular Pharmaceutics (ACS) 20(1), 663-679. (Impact factor: 5.364)
3. Suseela, M. N. L., Viswanadh, M. K., Mehata, A. K., Priya, V., Setia, V. A., Malik, A. K., Gokul, P., Selvin, J. & Muthu, M. S. (2023). Advances in solid-phase extraction techniques: role of nanosorbents for the enrichment of antibiotics for analytical quantification. Journal of Chromatography A, 463937. (Impact Factor: 4.601)
4. Vikas, Sahu, H. K., Mehata, A. K., Viswanadh, M. K., Priya, V., & Muthu, M. S. (2022), Dual-receptor-targeted nanomedicines: emerging trends and advances in lung cancer therapeutics. Nanomedicine (Lond).17(19), 1375-1395. (Impact Factor: 6.096).
5. Singh, C., Mehata, A.K., Priya, V., Malik, A.K., Setia, A., Suseela, M.N.L., Gokul, P., Singh, S.K. and Muthu, M.S., (2022). Bimetallic Au–Ag Nanoparticles: Advanced Nanotechnology for Tackling Antimicrobial Resistance. Molecules, 27(20), 7059. (Impact factor: 4.927)
6. Rout, S.K., Priya, V., Mehata, A.K. and Muthu, M.S., (2022). Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology, 76, 103785. (Impact factor: 4.950)
7. Rout, S.K., Priya, V., Setia, A., Mehata, A.K., Mohan, S., Albratty, M., Najmi, A., Meraya, A.M., Makeen, H.A., Tambuwala, M.M. and Muthu, M.S., (2022). Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy. Biomedicine & Pharmacotherapy, 153, 113451. (Impact factor: 7.419)
8. Manners, N., Priya, V., Mehata, A.K., Rawat, M., Mohan, S., Makeen, H.A., Albratty, M., Albarrati, A., Meraya, A.M. and Muthu, M.S., 2022. Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives. Pharmaceuticals, 15(4), 441. (Impact factor: 5.215)
9. Priya, V., Viswanadh, M.K., Mehata, A.K., Jain, D., Singh, S.K. and Muthu, M.S., (2021). Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis. Nanomedicine, 16(13), 1153-1176. (Impact factor: 6.096)
10. Dehari, D., Mehata, A.K., Priya, V., Parbat, D., Kumar, D., Srivastava, A.K., Singh, S. and Agrawal, A.K., (2022). Luliconazole nail lacquer for the treatment of onychomycosis: formulation, characterization and in vitro and ex vivo evaluation. AAPS PharmSciTech, 23(6), 1-17. (Impact factor: 4.026)
11. Viswanadh, M.K., Mehata, A.K., Sharma, V., Priya, V., Varshney, N., Mahto, S.K. and Muthu, M.S., (2021). Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment. Carbohydrate Polymers, 274, 118617. (Impact factor: 10.72)
12. Mehata, A.K., Viswanadh, M.K., Priya, V., Vikas and Muthu, M.S., (2021). Harnessing immunological targets for COVID-19 immunotherapy. Future Virology, 16(9), 619-640. (Impact factor: 3.015)
13. Viswanadh, M.K., Vikas, Jha, A., Reddy Adena, S.K., Mehata, A.K., Priya, V., Neogi, K., Poddar, S., Mahto, S.K. and Muthu, M.S., (2020). Formulation and in vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for non-small-cell lung cancer therapy. Nanomedicine, 15(24), 2345-2367. (Impact factor: 6.096)
14. Mehata, A.K., Viswanadh, M.K., Priya, V., Vikas and Muthu, M.S., (2020). Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy. Nanomedicine, 15(10), 947-949. (Impact factor: 6.096)
15. Narendra, Mehata, A.K., Viswanadh, M.K., Sonkar, R., Pawde, D.M., Priya, V., Singh, M., Koch, B. and S Muthu, M., (2020). Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Therapeutic Delivery, 11(9), 557-571.
16. Vikas, Viswanadh, M.K., Priya, V., Mehata, A.K. and Muthu, M.S., 2020. What are the unexplored facts about nanomicelles formed from docetaxel clinical injection?. Therapeutic Delivery, 11(1), 801-803.